VNRX

Volitionrx

• Dow Jones·13h ago

  VolitionRX Is Maintained at Buy by D. Boral Capital

• PR Newswire·19h ago

  Volition Reports Breakthrough in Liquid Biopsy: Achievement of over 99% Purity in Isolating Cancer DNA

• TipRanks·03/06 13:18

  VolitionRx announces automated Nu.Q Vet Cancer Test with Fujifilm Vet Systems

• PR Newswire·02/25 13:10

  VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution

• TipRanks·02/20 22:47

  VolitionRx Issues Shares to Satisfy Convertible Note Obligations

• PR Newswire·02/10 13:07

  Volition Announces the Appointment of New Distributor for Nu.Q® Discover

• Seeking Alpha·02/09 22:29

  VolitionRx receives NYSE non-compliance notice

• TipRanks·02/09 22:20

  VolitionRx files to sell 17.97M shares of common stock for holders

• PR Newswire·02/04 13:45

  Volition Sponsors Symposium at 15th Conference of the European Hidradenitis Suppurativa Foundation

• TipRanks·01/30 13:55

  VolitionRx preparing reimbursement submission for Nu.Q cancer assays in France

• Dow Jones·01/21 12:57

  VolitionRX Is Maintained at Buy by D. Boral Capital

• TipRanks·01/20 13:38

  VolitionRx adds two laboratories providing its vet cancer test in U.S. and Asia

• PR Newswire·01/20 13:25

  Volition Continues to Extend Access to Nu.Q® Vet Cancer Test

• PR Newswire·01/16 13:45

  Volition Sponsors Symposium at Veterinary Meeting and Expo